# Safety and Efficacy Study of DUR-928 Topical Solution in Subjects With Plaque Psoriasis

> **NCT03837743** · PHASE2 · COMPLETED · sponsor: **Durect** · enrollment: 25 (actual)

## Conditions studied

- Plaque Psoriasis

## Interventions

- **DRUG:** DUR-928 Topical Solution
- **DRUG:** Vehicle Topical Solution

## Key facts

- **NCT ID:** NCT03837743
- **Lead sponsor:** Durect
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-21
- **Primary completion:** 2019-11-11
- **Final completion:** 2020-05-20
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2022-09-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03837743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03837743, "Safety and Efficacy Study of DUR-928 Topical Solution in Subjects With Plaque Psoriasis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT03837743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*